TrueMark Investments LLC boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 117.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 37,160 shares of the company’s stock after acquiring an additional 20,089 shares during the quarter. TrueMark Investments LLC’s holdings in Colgate-Palmolive were worth $2,971,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the business. Grimes & Company Inc. boosted its holdings in shares of Colgate-Palmolive by 1.0% during the second quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after purchasing an additional 118 shares during the period. RFG Advisory LLC lifted its position in Colgate-Palmolive by 1.4% in the 2nd quarter. RFG Advisory LLC now owns 9,227 shares of the company’s stock worth $839,000 after buying an additional 123 shares in the last quarter. Tiemann Investment Advisors LLC boosted its stake in shares of Colgate-Palmolive by 2.1% during the 2nd quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after buying an additional 125 shares during the period. Westside Investment Management Inc. grew its holdings in shares of Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock valued at $26,000 after acquiring an additional 130 shares in the last quarter. Finally, S.A. Mason LLC increased its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after acquiring an additional 130 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.
Analyst Ratings Changes
A number of research firms recently issued reports on CL. Morgan Stanley reduced their price objective on Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. TD Cowen lowered their price target on Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating for the company in a research note on Thursday, January 8th. Evercore ISI dropped their price objective on Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating on the stock in a report on Monday, November 3rd. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $88.00 to $93.00 and gave the company an “overweight” rating in a research note on Friday, January 16th. Finally, Argus reissued a “hold” rating on shares of Colgate-Palmolive in a research report on Thursday, December 11th. Eleven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $89.44.
Colgate-Palmolive Trading Up 1.0%
NYSE:CL opened at $86.67 on Friday. The company’s 50 day moving average is $80.07 and its 200-day moving average is $81.58. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The firm has a market cap of $69.86 billion, a price-to-earnings ratio of 24.28, a P/E/G ratio of 5.82 and a beta of 0.30.
Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.02. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. Colgate-Palmolive’s revenue was up 1.9% compared to the same quarter last year. During the same period last year, the business posted $0.91 EPS. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date is Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. Colgate-Palmolive’s payout ratio is presently 58.26%.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Read More
- Five stocks we like better than Colgate-Palmolive
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Trump’s AI Secret: 100X Faster Than Nvidia
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
